Theory and practice of intellectual property
№ 3 / 2023

ISSN (Print) 2308-0361
ISSN (Online) 2519-2744

DOI: https://doi.org/10.33731/32023.282331

Submitted     2023-04-18
Accepted      2023-05-17
Published      2023-06-19

Abuse of patentability criteria when patenting inventionsrelated to medicines

Sergiy Kondratyuk
PhD student at the Intellectual Property Scientific Research Institute of the National Academy of Legal Sciences of Ukraine
Ukraine
https://orcid.org/0009-0006-3950-8217

Abstract
It is well known that intellectual property monopolies for medicines reduce physical and economic availability. The main purpose of the study is to conduct a brief review of foreign scholarly views on evergreening patenting practice in the field of pharmaceuticals, to demonstrate the implications of such abusive practice, and to exemplify good practices used in several countries to address the problem. Evergreening practice poses a serious challenge for the healthcare system of Ukraine, but there are promising examples in several countries (e.g., Argentina, Brazil, India) of limiting evergreening.

Keywords: evergreening, secondary patents, TRIPS flexibilities, patentability criteria, medicines, pharmaceuticals

References

Report of the United Nations Secretary-General’s High Level Panel on Access to Medicines: Promoting Innovation and Access to Health Technologies, 2016, 70.
http://www.unsgaccessmeds.org/final-report

Колективний лист пацієнтів з муковісцидозом та пацієнтських організацій до МОЗ України від 6 лютого 2023 щодо «Доступу до ліків від муковісцидозу Трикафта/Кафтріо (та інших препаратів компанії Vertex) для пацієнтів України».

Лист МОЗ України 25-04/KO-1267//2586-зв від 16 березня 2023.

Лінпарза таблетки, в/плів. Обол. По 150 мг №56 (8х7): ціна у Києві, Tabletki.ua (портал фармацевтичної продукції).
https://tabletki.ua/uk/%D0%9B%D0%B8%D0%BD%D0%BF%D0%B0%D1%80%D0%B7%D0%B0/39753/pharmacy/kiev/

Olaparib Dosage. Drugs.com, last updated 8 December 2022.
https://www.drugs.com/dosage/olaparib.html#Usual_Adult_Dose_for_Prostate_Cancer

Olaparib Brancanat tablets 100mg and 150mg, IndiaMART marketplace.
https://www.indiamart.com/proddetail/olaparib-bracanat-tablets-2850369330191.html

Correa C., Hilty R. Access to Medicines and Vaccines: Implementing Flexibilities Under Intellectual Property Law. Springer Cham, 2022. 373 p.
https://doi.org/10.1007/978-3-030-83114-1

UNDP, Good practice guide: Improving Access to Treatment by Utilizing Public Health Flexibilities in the WTO TRIPS Agreement, December 2010, 84.
https://www.undp.org/sites/g/files/zskgke326/files/publications/Good%20Practice%20Guide-Improving%20access%20to%20treatment%20by%20utilizing%20public%20health%20flexibilities%20in%20the%20WTO%20TRIPS%20agreement.pdf

Кашинцева О. Ю. Досвід України з імплементації гнучких положень Угоди ТРІПС у двох контекстах: євроінтеграції та пандемії. Теорія і практика інтелектуальної власності. 2021. № 5.
https://doi.org/10.33731/52021.244533

Пономарьова О. Примусова, відкрита та добровільна ліцензії на лікарські засоби: деякі аспекти правозастосування. Теорія і практика інтелектуальної власності. 2019. № 3.
https://doi.org/10.33731/32019.173811

Жихарев О. Особливості проведення експертизи патентів на лікарські засоби, Теорія і практика інтелектуальної власності. 2022. № 6.
https://doi.org/10.33731/62022.274630

Gurgula O. The ‘obvious to try’ method of addressing strategic patenting: How developing countries can utilize patent law to facilitate access to medicines. Policy Brief, South Centre, 2019.
https://www.southcentre.int/wp-content/uploads/2019/04/PB59_The-obvious-to-try-method-of-addressing-strategic-patenting_EN.pdf

South Centre, Correa C., February 2016, Implementing Pro-Competitive Criteria for the Examination of Pharmaceutical Patents, 44.
https://www.southcentre.int/wp-content/uploads/2016/02/RP64_Examination-of-pharma-patents_EN.pdf

UNDP, Correa С. Guidelines for the Examination of Patent Applications relating that Pharmaceuticals: Examining Pharmaceutical Patents From a Public Health Perspective , New York 2016, 48.
https://www.undp.org/publications/guidelines-examination-patent-applications-relating-pharmaceuticals

Kapczynski A, Park C, Sampat B (2012) Polymorphs and Prodrugs and Salts (Oh My!): An Empirical Analysis of “Secondary” Pharmaceutical Patents. PLoS ONE 7(12): e49470.
https://doi.org/10.1371/journal.pone.0049470

EC Competition DG, 2009, Pharmaceutical Sector Inquiry: Final Report, 533.
https://ec.europa.eu/competition/sectors/pharmaceuticals/inquiry/staff_working_paper_part1.pdf

Tahir Amin and Aaron S. Kesselheim, Secondary Patenting of Branded Pharmaceuticals: A Case Study of How Patents on Two HIV Drugs Could Be Extended for Decades, Health Affairs, 31, no. 10 (2012), 9.
https://www.healthaffairs.org/doi/10.1377/hlthaff.2012.0107

Chaves, Viera et al., 2018, Medicines under Exclusivity Situation Funded by the Ministry of Health: Analysis of the Patent Situation and Public Procurement, Rio de Janeiro, Fiocruz/ENSP, 200.
https://accessibsa.org/media/2020/11/Medicines-under-Exclusivity-Situation-funded-by-the-Ministry-of-Health.pdf

AbbVie Inc. v Amgen Inc. Complaint in the US District Court DE, 4 August, 2016, 49.
https://www.bigmoleculewatch.com/wp-content/uploads/sites/2/2016/08/ded-1-99-cv-de431-1.pdf

Phebe Hong, Stopping the Pharmaceutical «Product Hop», Bill of Health, the blog of the Petrie-Flom Center at Harvard Law School, 11 October 2019.
https://blog.petrieflom.law.harvard.edu/2019/10/11/stopping-the-pharmaceutical-product-hop/

Evergreening patents may make drugs too costly for patients in Thailand (Generics and Biosimilars Initiative, 2013).
https://www.gabionline.net/policies-legislation/Evergreening-patents-may-make-drugs-too-costly-for-patients-in-Thailand

Association Agreement between the European Union and its Member States, of the one part, and Ukraine, of the other part, 27 June 2014.
https://www.kmu.gov.ua/storage/app/sites/1/uploaded-files/TITLE%20IV.pdf

Petrenko S., Zhykharev O., Trofymentko M., Evegreening patents in Ukraine: Report, 2020, 100% Life, 60.
https://network.org.ua/wp-content/uploads/2020/12/Report-eng-curves-1-1.pdf

Christopher M. Holman, Timo Minssen, and Eric M. Solovy. Patentability Standards for Follow-On Pharmaceutical Innovation. Biotechnology Law Report.Jun 2018.131-161.
http://doi.org/10.1089/blr.2018.29073.cmh

Melissa J Barber , Dzintars Gotham , Giten Khwairakpam , and Andrew Hill . 9/2020. ” Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries .” Journal of Virus Eradication, 6, 3. Publisher’s Version.
https://www.sciencedirect.com/science/article/pii/S2055664020300017

MedsPal: the Medicines Patents and Licenses Database, Medicines Patent Pool.
https://www.medspal.org/?page=1

Patent on Hep C drug rejected in Ukraine: Price of sofosbuvir will significantly reduce, 14 March 2018, Make Medicines Affordable Campaign website, ITPC Global.
https://makemedicinesaffordable.org/patent-on-hep-c-drug-rejected-in-ukraine-price-of-sofosbuvir-will-significantly-reduce/

Argentine Joint Resolution 118/2012, 546/2012 and 107/2012 (Ministry of Industry, Ministry of Health and National Industrial Property Institute), Adoption of Guidelines for the Examination of Patent Applications of Chemical and Pharmaceutical Inventions, 2012, 8.
https://www.wipo.int/edocs/lexdocs/laws/es/ar/ar109es.pdf

German Velasquez, Research Paper, SC 2015, Guidelines on patentability and access to medicines, 44.
https://www.southcentre.int/wp-content/uploads/2015/03/RP61_Guidelines-on-Patentability-and-A2M_rev2_EN.pdf

Vieira, Di Giano, 2018, Taking on the challenge of implementing public health safeguards on the ground, in Routledge Handbook on the Politics of Global Health.
https://www.taylorfrancis.com/chapters/edit/10.4324/9781315297255-32/taking-challenge-implementing-public-health-safeguards-ground-marcela-foga%C3%A7a-vieira-lorena-di-giano

Park, Chan. 2010. “Chapter 2A: Implementation of India’s Patent Law: A Review of Patents Granted by the Indian Patent Office.” In Five Years into the Product Patent Regime: India’s Response, by Sudip Chaudhuri, Chan Park, and KM Gopakumar. United Nations Development Programme.
https://doi.org/10.13140/RG.2.1.4584.0088

Ali, Feroz, Sudarsan Rajagopal, Venkata S. Raman, and Roshan John. 2018. «Pharmaceutical Patent Grants in India: How Our Safeguards against Evergreening Have Failed, and Why the System Must Be Reformed».
https://www.accessibsa.org/media/2018/04/Pharmaceutical-Patent-Grants-in-India.pdf

Breakthrough success as reformed patent law enters into force in Ukraine, 21 August 2020.
https://makemedicinesaffordable.org/breakthrough-success-as-reformed-patent-law-enters-into-force-in-ukraine/

Закон України «Про внесення змін до деяких законодавчих актів України щодо реформи патентного законодавства від 21 липня 2020 № 816-IX.
https://zakon.rada.gov.ua/laws/show/816-20#n96

Про захист інтересів осіб у сфері інтелектуальної власності під час дії воєнного стану, введеного у зв’язку із збройною агресією Російської Федерації проти України: Закон України від 1 квітня 2023 №2174-IX.
https://zakon.rada.gov.ua/laws/show/2174-20#Text